XML 74 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The following table summarizes the Company’s outstanding swap contracts as of March 31, 2020 (dollars in thousands):
Date Entered
 
Maturity Date
 
Hedge Designation
 
Notional
 
Pay Rate
 
Receive Rate
 
Fair Value(1)
Interest rate:
 
 
 
 
 
 

 
 
 
 
 
 

July 2005(2)
 
July 2020
 
Cash Flow
 
$
42,000

 
3.82%
 
BMA Swap Index
 
$
(252
)
______________________________________
(1)
Derivative liabilities are recorded in accounts payable, accrued liabilities, and other liabilities in the consolidated balance sheets.
(2)
Represents three interest-rate swap contracts, which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.
The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes. Assuming a one percentage point shift in the underlying interest rate curve, the estimated change in fair value of each of the underlying derivative instruments would not exceed $1 million.
Concurrent with the sale of its remaining interest in the U.K. JV in December 2019 (see Note 7), the Company paid-off the remainder of its GBP-denominated borrowings under the Revolving Facility and terminated its previously-designated net investment hedge.